查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
自閉症譜系障礙治療市場規模、份額和趨勢分析報告:按治療類型（興奮劑、抗精神病藥）、應用、分銷渠道、地區、細分市場預測 2023-2030 年
市場調查報告書
商品編碼
1178547

自閉症譜系障礙治療市場規模、份額和趨勢分析報告:按治療類型（興奮劑、抗精神病藥）、應用、分銷渠道、地區、細分市場預測 2023-2030 年

Autism Spectrum Disorder Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Stimulants, Antipsychotic Drugs), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

自閉症譜系障礙治療市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，從 2023 年到 2030 年，全球自閉症譜系障礙治療市場規模將以 6.1% 的複合年增長率擴大，到 2030 年將達到 32.8 億美元。學術研究和製藥公司管道中的許多實驗性自閉症譜系障礙 (ASD) 藥物評估了關於基因指紋和大腦如何促進自閉症發展的重要理論。管道藥物包括來自 Axial Therapeutics 的 AB-2004 和 AB-2004 PTR，來自 Zynerva Pharmaceuticals 的 Zygel 和來自 Impel Pharmaceuticals 的 INP105（Olanzapine）。

2022 年 7 月，Impel Pharmaceuticals Inc.在評估 INP-105治療自閉症譜系障礙（ASD）青少年急性激越的 2a 期試驗中啟動了首例患者給藥。憑藉其 POD（精確嗅覺輸送）技術，該公司可以在不注射的情況下將藥物輸送到鼻尖，增加藥物吸收。因此，藥物輸送技術的進步有望推動市場。

2020 年 5 月，HARMAN International 和 F. Hoffmann-La Roche Ltd. 建立全球合作夥伴關係，為 ASD 患者開發數字治療平台。在這一合作夥伴關係下，Harman 和 Samsung 將其廣泛的技術與 F. Hoffmann-La Roche Ltd. 在神經科學方面的領導地位相結合，開發治療 ASD 的創新療法。

提高對自閉症譜系障礙研發的認識和資金預計將對市場增長產生積極影響。例如，羅馬第一大學將每年 4 月 2 日定為世界自閉症意識日，旨在提高醫生和患者對該疾病及其治療益處的認識。此外，在 2022 年 11 月，Defiance County Board of Developmental Disabilities/Good Samaritan School 和 Andrew Jimenez Autism Foundation 將從 Buckeye Roofing and Exteriors Owners 那裡獲得 1000 美元，以支持提高人們對 ASD 的認識的努力。捐贈並隨後為市場增長創造機會.

自閉症譜系障礙治療市場報告重點

按治療類型劃分，興奮劑部分在 2022 年所佔份額最大。這可以歸因於 FDA 批准的用於疾病症狀管理的興奮劑的市場可用性。

從應用來看，由於自閉症發病率上升，自閉症領域在 2022 年佔據了市場主導地位。三項隊列研究發現，截至 2021 年 5 月，ASD 發病率超過人口的 3%

到 2022 年，醫院藥房部門將佔據第二大份額。這種增長可歸因於診斷和治療該病患者的住院人數增加。

由於醫療保健專業人員對自閉症譜系障礙治療的高度認識、治療藥物的可用性以及疾病流行率的增加等因素，北美在 2022 年主導了全球市場

目錄

第一章 調查方法和範圍

  • 市場細分和範圍
    • 段範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 第一次調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 商品流向分析
      • 方法:產品流方法
  • 調查假設
  • 二級信息列表
  • 縮略語表
  • 目的

第二章執行摘要

  • 市場快照
  • 段快照
  • 爭用快照

3 自閉症譜系障礙治療:市場變量、趨勢和範圍

  • 市場系列展望
    • 中樞神經系統藥物市場
  • 繪製滲透率和增長前景
  • 監管狀況
  • 市場動態
  • 市場驅動力分析
    • 自閉症患病率增加
    • 提高醫生和患者對 ASD 的認識
    • 增加對 ASD 研究和開發的資助
  • 市場約束因素分析
    • 缺乏批准的藥物
    • 未能將靶向治療從臨床前轉化為臨床
  • PESTEL 分析
  • 行業分析——波特五力
  • 管道分析

4 自閉症譜系障礙治療市場:細分分析，按治療類型，2018-2030 年（百萬美元）

  • 自閉症譜系障礙治療市場:治療類型變化分析
  • 抗精神病藥
    • 選擇性血清素再攝取抑製劑
    • 興奮劑
    • 安眠藥
    • 其他

5. 自閉症譜系障礙治療市場:細分分析，按應用，2018-2030 年（百萬美元）

  • 自閉症譜系障礙治療市場:應用差異分析
  • 自閉症
  • 阿斯伯格綜合症
  • 廣泛性發育障礙
  • 其他

6 自閉症譜系障礙治療市場:細分分析，按分銷渠道，2018-2030 年（百萬美元）

  • 自閉症譜系障礙治療市場:分銷渠道的變化分析
  • 醫院藥房
  • 零售藥店
  • 網上藥店

7. 歐洲自閉症譜系障礙治療市場:按藥物類別、應用、給藥途徑和分銷渠道進行區域估計和趨勢分析

  • 北美
    • SWOT分析
    • 美國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 加拿大
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
  • 歐洲
    • SWOT分析
    • 英國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 處方和配藥場景
    • 德國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 法國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 意大利
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 西班牙
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 丹麥
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 瑞典
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 挪威
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 歐洲其他地區
  • 亞太地區
    • SWOT分析
    • 日本
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 處方和配藥場景
    • 中國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 印度
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 澳大利亞
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 韓國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 泰國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 亞太地區其他國家
  • 拉丁美洲
    • SWOT分析
    • 巴西
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
      • 處方和配藥場景
    • 墨西哥
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 阿根廷
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
  • 中東和非洲 (MEA)
    • SWOT分析
    • 南非
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 沙特阿拉伯
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 阿拉伯聯合酋長國
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • 科威特
      • 國家動態
      • 目標疾病的患病率
      • 競爭情景
      • 監管框架
      • 贖回場景
    • MEA 的其餘部分

8 自閉症譜系障礙治療市場:競爭分析

  • 主要市場進入者的最新發展和影響分析
    • 新產品發布
    • 併購
    • 許可協議
    • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要經銷商及渠道合作夥伴名單
    • 主要客戶
  • 上市公司
    • 2022 年主要參與者的市場份額分析
    • 公司市場分析
    • 熱圖分析
    • 競爭儀錶盤分析
      • 市場差異化因素
  • 民營企業
    • 主要初創企業名單
    • 區域網絡圖
  • 公司簡介
    • Curemark LLC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Bristol-Myers Squibb Company
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Merck & Co., Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Novartis AG
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Eli Lilly and Company
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Pfizer Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Johnson & Johnson Services, Inc.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Otsuka Pharmaceutical Co., Ltd.
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • Yamo Pharmaceuticals
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • F. Hoffmann-La Roche Ltd.
      • 公司簡介
      • 產品基準
      • 戰略舉措
    • Axial Therapeutics Inc.
      • 公司簡介
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-009-9

Autism Spectrum Disorder Treatment Market Growth & Trends:

The global autism spectrum disorder treatment market size is expected to reach USD 3.28 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% from 2023 to 2030. Many of the experimental autism spectrum disorder (ASD) drugs in the academic studies and pharma pipeline are assessing important theories about how the genetic fingerprint and brain contribute to the development of autism. Some of the pipeline drugs include AB-2004 & AB-2004 PTR by Axial Therapeutics, Inc., Zygel by Zynerba Pharmaceuticals, Inc., and INP105 (Olanzapine) by Impel Pharmaceuticals Inc.

In July 2022, Impel Pharmaceuticals Inc. initiated the first patient dose in phase 2a study evaluating INP-105 to treat acute agitation in adolescents with autism spectrum disorder (ASD). The company uses its Precision Olfactory Delivery (POD) technology to deliver medicine to the upper nasal part and increase the absorption of the drug, without the need for injection. Thus, technological advancement in drug delivery is anticipated to drive the market.

In May 2020, HARMAN International and F. Hoffmann-La Roche Ltd. entered into a global partnership to develop a digital therapeutic platform for individuals with ASD. Under this partnership, Harman and Samsung combined their extensive technology with F. Hoffmann-La Roche Ltd.'s leadership in neuroscience to develop innovative therapies for the treatment of ASD.

Rising awareness and funding for research and development of autism spectrum disorder are expected to positively contribute to the growth of the market. For instance, the Sapienza Universita di Roma every year celebrates the 2nd of April as 'World Autism Awareness Day' with an aim to increase awareness about the disease and its treatment benefits among physicians and patients. Furthermore, in November 2022, the Defiance County Board of Developmental Disabilities/Good Samaritan School and the Andrew Jimenez Autism Fund received a donation of USD 1000 from Buckeye Roofing and Exteriors owner to support the efforts to raise awareness about ASD, subsequently creating an opportunity for the market growth.

Autism Spectrum Disorder Treatment Market Report Highlights:

  • By treatment type, the stimulants segment accounted for the largest share in 2022. This can be attributed to the availability of FDA-approved stimulants for the symptom management of disease in the market
  • Based on application, the autistic disorder segment dominated the market in 2022 owing to the rising incidence of the disease. As per the 3 cohort studies, the incidence of ASD was found to be more than 3% of the population as of May 2021
  • The hospital pharmacy segment held the second-largest share in 2022. This growth can be attributed to an increase in inpatient visits for the diagnosis and treatment of patients with disease
  • North America dominated the global market in 2022 owing to factors such as high awareness among healthcare professionals about autism spectrum disorder treatment, the availability of drugs for treatment, and an increase in disease prevalence

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation and Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Snapshot

Chapter 3 Autism Spectrum Disorder Treatment: Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Central Nervous System Therapeutics Market
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
  • 3.5 Market Driver Analysis
    • 3.5.1 Increasing Prevalence of ASD
    • 3.5.2 Increasing Awareness About ASD Among Physicians and Patients
    • 3.5.3 Increasing Funding for ASD R&D
  • 3.6 Market Restraint Analysis
    • 3.6.1 Lack of Approved Drugs
    • 3.6.2 Failures of Preclinical to Clinical Translation of Targeted Treatments
  • 3.7 PESTEL Analysis
  • 3.8 Industry Analysis-Porter's Five Forces
  • 3.9 Pipeline Analysis

Chapter 4 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Treatment Type, 2018 - 2030 (USD Million)

  • 4.1 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
  • 4.2 Antipsychotic Drugs
    • 4.2.1 Antipsychotic Drugs Market, 2018 - 2030 (USD Million)
    • 4.2.2 Selective Serotonin Reuptake Inhibitors
      • 4.2.2.1 Selective Serotonin Reuptake Inhibitors Market, 2018 - 2030 (USD Million)
    • 4.2.3 Stimulants
      • 4.2.3.1 Stimulants Market, 2018 - 2030 (USD Million)
    • 4.2.4 Sleep Medication
      • 4.2.4.1 Sleep Medication Market, 2018 - 2030 (USD Million)
    • 4.2.5 Others
      • 4.2.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 5 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)

  • 5.1 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
  • 5.2 Autistic Disorder
    • 5.2.1 Autistic Disorder Market, 2018 - 2030 (USD Million)
  • 5.3 Asperger Syndrome
    • 5.3.1 Asperger Syndrome Market, 2018 - 2030 (USD Million)
  • 5.4 Pervasive Developmental Disorder
    • 5.4.1 Pervasive Developmental Disorder Market, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Autism Spectrum Disorder Treatment Market: Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)

  • 6.1 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
  • 6.2 Hospital Pharmacy
    • 6.2.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.3 Retail Pharmacy
    • 6.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
  • 6.4 Online Pharmacy
    • 6.4.1 Online Pharmacy Market, 2018 - 2030 (USD Million)

Chapter 7 Europe Autism Spectrum Disorder Treatment Market: Regional Estimates and Trend Analysis, by Drug Class, Application, Route of Administration, & Distribution Channel

  • 7.1 North America
    • 7.1.1 SWOT Analysis:
      • 7.1.1.1 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.1.2 U.S.
      • 7.1.2.1 Country Dynamics
      • 7.1.2.2 Target Disease Prevalence
      • 7.1.2.3 Competitive Scenario
      • 7.1.2.4 Regulatory Framework
      • 7.1.2.5 Reimbursement Scenario
      • 7.1.2.6 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.1.3 Canada
      • 7.1.3.1 Country Dynamics
      • 7.1.3.2 Target Disease Prevalence
      • 7.1.3.3 Competitive Scenario
      • 7.1.3.4 Regulatory Framework
      • 7.1.3.5 Reimbursement Scenario
      • 7.1.3.6 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2 Europe
    • 7.2.1 SWOT Analysis:
      • 7.2.1.1 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2 U.K.
      • 7.2.2.1 Country Dynamics
      • 7.2.2.2 Target Disease Prevalence
      • 7.2.2.3 Competitive Scenario
      • 7.2.2.4 Regulatory Framework
      • 7.2.2.5 Reimbursement Scenario
      • 7.2.2.6 Prescription and Dispensing Scenario
      • 7.2.2.7 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3 Germany
      • 7.2.3.1 Country Dynamics
      • 7.2.3.2 Target Disease Prevalence
      • 7.2.3.3 Competitive Scenario
      • 7.2.3.4 Regulatory Framework
      • 7.2.3.5 Reimbursement Scenario
      • 7.2.3.6 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4 France
      • 7.2.4.1 Country Dynamics
      • 7.2.4.2 Target Disease Prevalence
      • 7.2.4.3 Competitive Scenario
      • 7.2.4.4 Regulatory Framework
      • 7.2.4.5 Reimbursement Scenario
      • 7.2.4.6 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.5 Italy
      • 7.2.5.1 Country Dynamics
      • 7.2.5.2 Target Disease Prevalence
      • 7.2.5.3 Competitive Scenario
      • 7.2.5.4 Regulatory Framework
      • 7.2.5.5 Reimbursement Scenario
      • 7.2.5.6 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.6 Spain
      • 7.2.6.1 Country Dynamics
      • 7.2.6.2 Target Disease Prevalence
      • 7.2.6.3 Competitive Scenario
      • 7.2.6.4 Regulatory Framework
      • 7.2.6.5 Reimbursement Scenario
      • 7.2.6.6 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.7 Denmark
      • 7.2.7.1 Country Dynamics
      • 7.2.7.2 Target Disease Prevalence
      • 7.2.7.3 Competitive Scenario
      • 7.2.7.4 Regulatory Framework
      • 7.2.7.5 Reimbursement Scenario
      • 7.2.7.6 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.8 Sweden
      • 7.2.8.1 Country Dynamics
      • 7.2.8.2 Target Disease Prevalence
      • 7.2.8.3 Competitive Scenario
      • 7.2.8.4 Regulatory Framework
      • 7.2.8.5 Reimbursement Scenario
      • 7.2.8.6 Sweden Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.9 Norway
      • 7.2.9.1 Country Dynamics
      • 7.2.9.2 Target Disease Prevalence
      • 7.2.9.3 Competitive Scenario
      • 7.2.9.4 Regulatory Framework
      • 7.2.9.5 Reimbursement Scenario
      • 7.2.9.6 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.11 Rest of Europe
      • 7.2.11.1 Rest of Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1 SWOT Analysis:
      • 7.3.1.1 Asia PacificAutism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2 Japan
      • 7.3.2.1 Country Dynamics
      • 7.3.2.2 Target Disease Prevalence
      • 7.3.2.3 Competitive Scenario
      • 7.3.2.4 Regulatory Framework
      • 7.3.2.5 Reimbursement Scenario
      • 7.3.2.6 Prescription and Dispensing Scenario
      • 7.3.2.7 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3 China
      • 7.3.3.1 Country Dynamics
      • 7.3.3.2 Target Disease Prevalence
      • 7.3.3.3 Competitive Scenario
      • 7.3.3.4 Regulatory Framework
      • 7.3.3.5 Reimbursement Scenario
      • 7.3.3.6 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4 India
      • 7.3.4.1 Country Dynamics
      • 7.3.4.2 Target Disease Prevalence
      • 7.3.4.3 Competitive Scenario
      • 7.3.4.4 Regulatory Framework
      • 7.3.4.5 Reimbursement Scenario
      • 7.3.4.6 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5 Australia
      • 7.3.5.1 Country Dynamics
      • 7.3.5.2 Target Disease Prevalence
      • 7.3.5.3 Competitive Scenario
      • 7.3.5.4 Regulatory Framework
      • 7.3.5.5 Reimbursement Scenario
      • 7.3.5.6 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6 South Korea
      • 7.3.6.1 Country Dynamics
      • 7.3.6.2 Target Disease Prevalence
      • 7.3.6.3 Competitive Scenario
      • 7.3.6.4 Regulatory Framework
      • 7.3.6.5 Reimbursement Scenario
      • 7.3.6.6 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7 Thailand
      • 7.3.7.1 Country Dynamics
      • 7.3.7.2 Target Disease Prevalence
      • 7.3.7.3 Competitive Scenario
      • 7.3.7.4 Regulatory Framework
      • 7.3.7.5 Reimbursement Scenario
      • 7.3.7.6 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8 Rest of APAC
      • 7.3.8.1 Rest of APAC Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Latin America
    • 7.4.1 SWOT Analysis:
      • 7.4.1.1 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2 Brazil
      • 7.4.2.1 Country Dynamics
      • 7.4.2.2 Target Disease Prevalence
      • 7.4.2.3 Competitive Scenario
      • 7.4.2.4 Regulatory Framework
      • 7.4.2.5 Reimbursement Scenario
      • 7.4.2.6 Prescription and Dispensing Scenario
      • 7.4.2.7 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3 Mexico
      • 7.4.3.1 Country Dynamics
      • 7.4.3.2 Target Disease Prevalence
      • 7.4.3.3 Competitive Scenario
      • 7.4.3.4 Regulatory Framework
      • 7.4.3.5 Reimbursement Scenario
      • 7.4.3.6 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4 Argentina
      • 7.4.4.1 Country Dynamics
      • 7.4.4.2 Target Disease Prevalence
      • 7.4.4.3 Competitive Scenario
      • 7.4.4.4 Regulatory Framework
      • 7.4.4.5 Reimbursement Scenario
      • 7.4.4.6 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Middle East & Africa (MEA)
    • 7.5.1 SWOT Analysis
      • 7.5.1.1 MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2 South Africa
      • 7.5.2.1 Country Dynamics
      • 7.5.2.2 Target Disease Prevalence
      • 7.5.2.3 Competitive Scenario
      • 7.5.2.4 Regulatory Framework
      • 7.5.2.5 Reimbursement Scenario
      • 7.5.2.6 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3 Saudi Arabia
      • 7.5.3.1 Country Dynamics
      • 7.5.3.2 Target Disease Prevalence
      • 7.5.3.3 Competitive Scenario
      • 7.5.3.4 Regulatory Framework
      • 7.5.3.5 Reimbursement Scenario
      • 7.5.3.6 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4 UAE
      • 7.5.4.1 Country Dynamics
      • 7.5.4.2 Target Disease Prevalence
      • 7.5.4.3 Competitive Scenario
      • 7.5.4.4 Regulatory Framework
      • 7.5.4.5 Reimbursement Scenario
      • 7.5.4.6 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5 Kuwait
      • 7.5.5.1 Country Dynamics
      • 7.5.5.2 Target Disease Prevalence
      • 7.5.5.3 Competitive Scenario
      • 7.5.5.4 Regulatory Framework
      • 7.5.5.5 Reimbursement Scenario
      • 7.5.5.6 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6 Rest of MEA
      • 7.5.6.1 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Autism Spectrum Disorder Treatment Market: Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 8.1.1 New Product Launch
    • 8.1.2 Merger and Acquisition
    • 8.1.3 Licensing Agreements
    • 8.1.4 Conferences and Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List of Key Distributors and Channel Partners
    • 8.3.2 Key Customers
  • 8.4 Public Companies
    • 8.4.1 Key Company Market Share Analysis, 2022
    • 8.4.2 Company Market Position Analysis
    • 8.4.3 Heat Map Analysis
    • 8.4.4 Competitive Dashboard Analysis
      • 8.4.4.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List of Key Emerging Companies
    • 8.5.2 Regional Network Map
  • 8.6 Company Profiles
      • 8.6.1.Curemark LLC
      • 8.6.1.1 Company Overview
      • 8.6.1.2 Financial Performance
      • 8.6.1.3 Product Benchmarking
      • 8.6.1.4 Strategic Initiatives
    • 8.6.2 Bristol - Myers Squibb Company
      • 8.6.2.1 Company Overview
      • 8.6.2.2 Financial Performance
      • 8.6.2.3 Product Benchmarking
      • 8.6.2.4 Strategic Initiatives
    • 8.6.3 Merck & Co., Inc.
      • 8.6.3.1 Company Overview
      • 8.6.3.2 Financial Performance
      • 8.6.3.3 Product Benchmarking
      • 8.6.3.4 Strategic Initiatives
    • 8.6.4 Novartis AG
      • 8.6.4.1 Company Overview
      • 8.6.4.2 Financial Performance
      • 8.6.4.3 Product Benchmarking
      • 8.6.4.4 Strategic Initiatives
    • 8.6.5 Eli Lilly and Company
      • 8.6.5.1 Company Overview
      • 8.6.5.2 Financial Performance
      • 8.6.5.3 Product Benchmarking
      • 8.6.5.4 Strategic Initiatives
    • 8.6.6 Pfizer Inc.
      • 8.6.6.1 Company Overview
      • 8.6.6.2 Financial Performance
      • 8.6.6.3 Product Benchmarking
      • 8.6.6.4 Strategic Initiatives
    • 8.6.7 Johnson & Johnson Services, Inc.
      • 8.6.7.1 Company Overview
      • 8.6.7.2 Financial Performance
      • 8.6.7.3 Product Benchmarking
      • 8.6.7.4 Strategic Initiatives
    • 8.6.8 Otsuka Pharmaceutical Co., Ltd.
      • 8.6.8.1 Company Overview
      • 8.6.8.2 Financial Performance
      • 8.6.8.3 Product Benchmarking
      • 8.6.8.4 Strategic Initiatives
    • 8.6.9 Yamo Pharmaceuticals
      • 8.6.8.1 Company Overview
      • 8.6.9.2 Financial Performance
      • 8.6.9.3 Product Benchmarking
      • 8.6.9.4 Strategic Initiatives
    • 8.6.10 F. Hoffmann - La Roche Ltd.
      • 8.6.10.1 Company Overview
      • 8.6.10.2 Product Benchmarking
      • 8.6.10.3 Strategic Initiatives
    • 8.6.11 Axial Therapeutics Inc.
      • 8.6.11.1 Company Overview
      • 8.6.11.2 Product Benchmarking
      • 8.6.11.3 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Autism Spectrum Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 6 Global Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 10 North America Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 U.S. Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Canada Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 16 Canada Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 Europe Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Germany Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 23 Germany Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 U.K. Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 26 U.K. Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 U.K. Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 France Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 29 France Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 Italy Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 32 Italy Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Spain Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 35 Spain Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Denmark Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 38 Denmark Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Sweden Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 41 Sweden Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Norway Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 44 Norway Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 China Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 54 China Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 India Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 57 India Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 South Korea Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 60 South Korea Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Australia Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 63 Australia Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Thailand Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 66 Thailand Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 Latin America Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 70 Latin America Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Brazil Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 73 Brazil Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 Mexico Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 76 Mexico Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 78 Argentina Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 79 Argentina Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 South Africa Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 89 South Africa Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 South Africa Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 91 UAE Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 92 UAE Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Autism Spectrum Disorder Treatment Market, By Treatment Type, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Autism Spectrum Disorder Treatment Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Autism Spectrum Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Autism Spectrum Disorder Treatment Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value - Chain - Based Sizing & Forecasting
  • Fig. 7 QFD Modeling For Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Commodity Flow Analysis
  • Fig. 10 Market Snapshot (2022) (USD Million)
  • Fig. 11 Segment Snapshot (2022) (USD Million)
  • Fig. 12 Segment Snapshot (2022) (USD Million)
  • Fig. 13 Competitive Snapshot
  • Fig. 14 Penetration and Growth Prospect Mapping
  • Fig. 15 Autism Spectrum Disorder Treatment Market Driver Impact
  • Fig. 16 Autism Spectrum Disorder Treatment Market Restraint Impact
  • Fig. 17 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 18 Porter's Five Forces Analysis
  • Fig. 19 Autism Spectrum Disorder Treatment Market: Treatment Type Outlook and Key Takeaways
  • Fig. 20 Autism Spectrum Disorder Treatment Market: Treatment Type Movement Analysis
  • Fig. 21 Antipsychotic Drugs Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Antimetabolites Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Selective Serotonin Reuptake Inhibitors Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 StimulantsMarket Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sleep Medications Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 OthersMarket Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Autism Spectrum Disorder Treatment Market: Application Outlook and Key Takeaways
  • Fig. 28 Autism Spectrum Disorder Treatment Market: Application Movement Analysis
  • Fig. 29 Autistic Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Asperger Syndrome Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Pervasive Developmental Disorder Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 32OthersMarket Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Autism Spectrum Disorder Treatment Market: Distribution Channel Outlook and Key Takeaways
  • Fig. 34 Autism Spectrum Disorder Treatment Market: Distribution Channel Movement Analysis
  • Fig. 35 Hospital Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Retail Pharmacy Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America: SWOT analysis
  • Fig. 40 North America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Country Dynamics
  • Fig. 42 U.S. Target Disease Prevalence
  • Fig. 43 U.S. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada Country Dynamics
  • Fig. 43 Canada Target Disease Prevalence
  • Fig. 44 Canada Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe: SWOT analysis
  • Fig. 46 Europe Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Country Dynamics
  • Fig. 48 Germany Target Disease Prevalence
  • Fig. 49 Germany Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.K. Country Dynamics
  • Fig. 51 U.K. Target Disease Prevalence
  • Fig. 52 U.K. Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France Country Dynamics
  • Fig. 54 France Target Disease Prevalence
  • Fig. 55 France Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Italy Country Dynamics
  • Fig. 57 Italy Target Disease Prevalence
  • Fig. 58 Italy Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain Country Dynamics
  • Fig. 60 Spain Target Disease Prevalence
  • Fig. 61 Spain Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark Country Dynamics
  • Fig. 63 Denmark Target Disease Prevalence
  • Fig. 64 Denmark Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Sweden Country Dynamics
  • Fig. 66 Sweden Target Disease Prevalence
  • Fig. 67 Sweden Autism Spectrum Disorder Treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Norway Country Dynamics
  • Fig. 69 Norway Target Disease Prevalence
  • Fig. 70 Norway Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Rest of Europe Autism Spectrum Disorder Treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific: SWOT Analysis
  • Fig. 75 Asia Pacific Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Japan Country Dynamics
  • Fig. 77 Japan Target Disease Prevalence
  • Fig. 78 Japan Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 China Country Dynamics
  • Fig. 80 China Target Disease Prevalence
  • Fig. 81 China Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 India Country Dynamics
  • Fig. 83 India Target Disease Prevalence
  • Fig. 84 India Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Australia Country Dynamics
  • Fig. 86 Australia Target Disease Prevalence
  • Fig. 87 Australia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 South Korea Country Dynamics
  • Fig. 89 South Korea Target Disease Prevalence
  • Fig. 90 South Korea Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Thailand Country Dynamics
  • Fig. 92 Thailand Target Disease Prevalence
  • Fig. 93 Thailand Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Rest of APAC Autism Spectrum Disorder Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America (LATAM): SWOT Analysis
  • Fig. 98 Latin America Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil Country Dynamics
  • Fig. 100 Brazil Target Disease Prevalence
  • Fig. 101 Brazil Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Mexico Country Dynamics
  • Fig. 103 Mexico Target Disease Prevalence
  • Fig. 104 Mexico Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Argentina Country Dynamics
  • Fig. 106 Argentina Target Disease Prevalence
  • Fig. 107 Argentina Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Rest of LATAM Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Middle East & Africa (MEA): SWOT Analysis
  • Fig. 112 Middle East & Africa (MEA) Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 South Africa Country Dynamics
  • Fig. 114 Target Disease Prevalence
  • Fig. 115 South Africa Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 116 Saudi Arabia Country Dynamics
  • Fig. 117 Saudi ArabiaTarget disease prevalence
  • Fig. 118 Saudi Arabia Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 UAE Country Dynamics
  • Fig. 120 UAE Target Disease Prevalence
  • Fig. 121 UAE Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Kuwait Country Dynamics
  • Fig. 123 Kuwait Target Disease Prevalence
  • Fig. 124 Kuwait Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Rest of MEA Autism Spectrum Disorder Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Heat Map Analysis
  • Fig. 129 Strategic Framework